Guangdong Transtek Medical Electronics Co., Ltd (SHE:300562)
China flag China · Delayed Price · Currency is CNY
12.73
-0.43 (-3.27%)
Nov 13, 2026, 3:04 PM CST

SHE:300562 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,043980.13978.02878.911,0601,816
Other Revenue
6.086.085.965.354.974.82
1,049986.21983.98884.261,0651,821
Revenue Growth
6.57%0.23%11.28%-16.98%-41.51%36.23%
Cost of Revenue
678.85640.63645.88606.35844.211,486
Gross Profit
370.58345.58338.1277.9220.88335.31
Selling, General & Admin
131.34146.66182.25144.41133.42172.94
Research & Development
97.595.196.81108.32136.93149.15
Other Operating Expenses
7.135.826.657.1110.055.77
Operating Expenses
238.51250.05286.7263.69285.62335.22
Operating Income
132.0795.5351.3914.22-64.740.09
Interest Expense
--2.36-5.35-4.28-2.42-2.57
Interest & Investment Income
6.0911.427.659.957.0711.41
Currency Exchange Gain (Loss)
-3.87-3.8717.237.0929.91-9.63
Other Non Operating Income (Expenses)
-11.56-1.670.350.02-0.63-1.31
EBT Excluding Unusual Items
122.7399.0571.2827.01-30.81-2.01
Impairment of Goodwill
-9.05-9.05-8.55--3.44-4.78
Gain (Loss) on Sale of Investments
1.490.43-0.140.79-6.310.22
Gain (Loss) on Sale of Assets
-1.38-0.030.09-0.470.38-0.05
Asset Writedown
-6.21-6.5-4.29-0.86-12.77-3.34
Legal Settlements
-1.55-1.55----
Other Unusual Items
0.881.991.646.648.396.76
Pretax Income
106.9184.3560.0433.11-44.57-3.21
Income Tax Expense
7.744.081.881.91-6.37-2.93
Earnings From Continuing Operations
99.1680.2758.1631.2-38.2-0.28
Minority Interest in Earnings
1.681.733.213.175.849.14
Net Income
100.848261.3634.37-32.368.87
Net Income to Common
100.848261.3634.37-32.368.87
Net Income Growth
31.79%33.63%78.55%---87.36%
Shares Outstanding (Basic)
218218217215216222
Shares Outstanding (Diluted)
218218217215216222
Shares Change
0.37%0.36%0.87%-0.24%-2.70%16.93%
EPS (Basic)
0.460.380.280.16-0.150.04
EPS (Diluted)
0.460.380.280.16-0.150.04
EPS Growth
31.29%33.15%77.02%---89.19%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
153.37138.3790.8761.2563.61-68.66
Free Cash Flow Per Share
0.700.640.420.280.29-0.31
Dividend Per Share
0.2600.2600.2800.1500.0100.010
Dividend Growth
-7.14%-7.14%86.67%1400.00%0%-95.00%
Gross Margin
35.31%35.04%34.36%31.43%20.74%18.41%
Operating Margin
12.58%9.69%5.22%1.61%-6.08%0.01%
Profit Margin
9.61%8.31%6.24%3.89%-3.04%0.49%
Free Cash Flow Margin
14.61%14.03%9.23%6.93%5.97%-3.77%
EBITDA
148.83114.5973.5138.09-40.7718.35
EBITDA Margin
14.18%11.62%7.47%4.31%-3.83%1.01%
D&A For EBITDA
16.7619.0522.1123.8723.9718.26
EBIT
132.0795.5351.3914.22-64.740.09
EBIT Margin
12.58%9.69%5.22%1.61%-6.08%0.01%
Effective Tax Rate
7.24%4.83%3.14%5.78%--
Revenue as Reported
1,049986.21983.98884.261,0651,821